🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/05/2005 | 32,51 | 32,57 | 32,16 | 32,44 | +0,29% | 1,26% | 5.918.056 |
| 29/04/2005 | 32,16 | 32,59 | 31,98 | 32,35 | +0,33% | 1,90% | 8.308.963 |
| 28/04/2005 | 31,92 | 32,29 | 31,76 | 32,24 | +0,90% | 1,67% | 6.406.738 |
| 27/04/2005 | 32,07 | 32,30 | 31,83 | 31,96 | -0,33% | 1,46% | 7.432.102 |
| 26/04/2005 | 32,34 | 32,42 | 31,87 | 32,06 | -0,94% | 1,71% | 7.701.542 |
| 25/04/2005 | 32,52 | 32,53 | 31,98 | 32,37 | -0,82% | 1,67% | 8.292.300 |
| 22/04/2005 | 32,71 | 32,82 | 32,38 | 32,63 | -0,23% | 1,37% | 7.480.100 |
| 21/04/2005 | 33,37 | 33,38 | 32,40 | 32,71 | +0,62% | 2,95% | 9.908.945 |
| 20/04/2005 | 32,82 | 32,98 | 32,06 | 32,51 | -1,76% | 2,79% | 9.044.030 |
| 19/04/2005 | 33,06 | 33,23 | 32,57 | 33,09 | +0,73% | 2,02% | 8.597.582 |
| 18/04/2005 | 33,16 | 33,16 | 32,44 | 32,85 | -1,06% | 2,16% | 10.906.536 |
| 15/04/2005 | 33,63 | 34,60 | 33,17 | 33,21 | +0,06% | 4,26% | 20.426.463 |
| 14/04/2005 | 33,02 | 33,37 | 32,95 | 33,19 | +0,75% | 1,27% | 14.846.492 |
| 13/04/2005 | 32,26 | 33,68 | 31,98 | 32,94 | +2,10% | 5,26% | 26.918.509 |
| 12/04/2005 | 31,54 | 32,27 | 31,44 | 32,26 | +2,02% | 2,63% | 8.287.584 |
| 11/04/2005 | 31,92 | 32,05 | 31,54 | 31,62 | -0,57% | 1,61% | 5.167.478 |
| 08/04/2005 | 32,16 | 32,19 | 31,66 | 31,80 | -0,48% | 1,66% | 7.620.532 |
| 07/04/2005 | 30,92 | 31,98 | 30,52 | 31,96 | +1,82% | 4,72% | 21.216.236 |
| 06/04/2005 | 31,72 | 31,90 | 31,26 | 31,38 | -0,45% | 2,02% | 8.133.423 |
| 05/04/2005 | 31,19 | 31,63 | 31,11 | 31,53 | +1,66% | 1,68% | 11.127.769 |
| 04/04/2005 | 30,90 | 31,05 | 30,59 | 31,01 | +0,59% | 1,48% | 8.984.714 |
| 01/04/2005 | 31,17 | 31,18 | 30,75 | 30,83 | -0,19% | 1,38% | 7.254.780 |
| 31/03/2005 | 30,93 | 31,11 | 30,69 | 30,89 | -0,22% | 1,36% | 8.397.519 |
| 30/03/2005 | 30,68 | 30,97 | 30,54 | 30,95 | +1,34% | 1,40% | 8.126.821 |
| 29/03/2005 | 30,31 | 30,70 | 30,31 | 30,54 | +0,79% | 1,29% | 8.025.270 |
| 28/03/2005 | 30,61 | 30,62 | 30,25 | 30,31 | -0,35% | 1,22% | 6.352.138 |
| 24/03/2005 | 30,62 | 30,67 | 30,34 | 30,41 | -0,59% | 1,06% | 5.898.773 |
| 23/03/2005 | 30,49 | 30,88 | 30,44 | 30,59 | +0,25% | 1,44% | 9.392.910 |
| 22/03/2005 | 30,53 | 30,62 | 30,25 | 30,52 | +0,44% | 1,22% | 8.574.317 |
| 21/03/2005 | 30,58 | 30,58 | 30,31 | 30,38 | -0,62% | 0,87% | 7.067.083 |